References
- 1. McConnell M, Actis L, Pachón J. Acinetobacter baumannii: human infections, factors contributing to pathogenesis and animal models. FEMS Microbiol Rev 2013;37:130-55. doi: 10.1111/j.1574-6976.2012.00344.x
- 2. Peleg AY, Scifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 2008;21:538-82. doi: 10.1128/CMR.00058-07
- 3. Wang C, Wang J, Pan H, Hu W, Li Y. Multidrug resistance and biofilm formation contribute to the nosocomial infections caused by Acinetobacter baumannii. In: Méndez-Vilas A, editor. The battle against microbial pathogens: basic science, technological advances and educational programs. Vol. 1. Badajoz: Formatex Research Center; 2015. p. 452-61.
- 4. Lee CR, Lee JH, Park M, Park KS, Bae IK, Kim YB, Cha CJ, Jeong BC, Lee SH. Biology of Acinetobacter baumannii: pathogenesis, antibiotic resistance mechanisms, and prospective treatment options. Front Cell Infect Microbiol 2017;7:55. doi: 10.3389/fcimb.2017.00055
- 5. Longo F, Vuotto C, Donelli G. Biofilm formation in Acinetobacter baumannii. New Microbiol 2014;37:119-27. PMID: 24858639
- 6. Bridier A, Briandet R, Thomas V, Dubois-Brissonnet F. Resistance of bacterial biofilms to disinfectants: a review. B i o f o u l i n g 2 0 1 1 ; 2 7 : 1 0 1 7 - 3 2 . d o i : 10.1080/08927014.2011.626899
- 7. Espinal P, Marti S, Vila J. Effect of biofilm formation on the survival of Acinetobacter baumannii on dry surfaces. J Hosp Infect 2012;80:56-60. doi: 10.1016/j.jhin.2011.08.013
- 8. Gayoso CM, Mateos J, Mendez JA, Fernandez-Puente P, Rumbo C, Tomas M, Martínez de Ilarduya O, Bou G. Molecular mechanisms involved in the response to desiccation stress and persistence in Acinetobacter baumannii. J Proteome Res 2014;13:460-76. doi: 10.1021/pr400603f
- 9. Gaddy JA, Actis LA. Regulation of Acinetobacter baumannii biofilm formation. Future Microbiol 2009;4:273-8. doi: 10.2217/fmb.09.5
- 10. Vickery K, Deva A, Jacombs A, Allan J, Valente P, Gosbell IB. Presence of biofilm containing viable multiresistant organisms despite terminal cleaning on clinical surfaces in an intensive care unit. J Hosp Infect 2012;80:52-5. doi: 10.1016/j.jhin.2011.07.007
- 11. Liu WL, Liang HW, Lee MF, Lin HL, Lin YH, Chen CC, Chang PC, Lai CC, Chuang YC, Tang HJ. The impact of inadequate terminal disinfection on an outbreak of imipenemresistant Acinetobacter baumannii in an intensive care unit. PLoS One 2014;9:e107975. doi: 10.1371/journal.pone.0107975
- 12. Lanjri S, Uwingabiye J, Frikh M, Abdellatifi L, Kasouati J, Maleb A, Bait A, Lemnouer A, Elouennass M. In vitro evaluation of the susceptibility of Acinetobacter baumannii isolates to antiseptics and disinfectants: comparison between clinical and environmental isolates. Antimicrob Resist Infect Control 2017;6:36. doi: 10.1186/s13756-017-0195-y
- 13. Sebit B, Aksu B, Karahasan Yagci A. Biofilm production and biocidal efficacy in multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii isolates. Int J Antisep Disinfect Steril 2016;1:7-12. doi: 10.14744/ijads.2016.08208
- 14. Kawamura-Sato K. Wachino J, Kondo T, Ito H, Arakawa Y. Correlation between reduced susceptibility to disinfectants and multidrug resistance among clinical isolates of Acinetobacter species. Antimicrob Chemother 2010;65:1975-83. doi: 10.1093/jac/dkq227
- 15. Babaei MR, Sulong A, Hamat RA, Nordin SA, Neela VK. Extremely high prevalence of antiseptic resistant Quaternary Ammonium Compound E gene among clinical isolates of multiple drug resistant Acinetobacter baumannii in Malaysia. Ann Clin Microbiol Antimicrob 2015;14:11. doi: 10.1186/s12941-015-0071-7
- 16. Ali NE, Morsi SS, Elgohary EA. Association between antibiotics and disinfectants resistance profiles among Acinetobacter baumannii isolates in Zagazig University Hospitals intensive care unit. Life Sci J 2014;11:1-8.
- 17. Martró E, Hernández A, Ariza J, Domínguez MA, Matas L, Argerich MJ, Martin R, Ausina V. Assessment of Acinetobacter baumannii susceptibility to antiseptics and disinfectants. J Hosp Infect 2003;55:39-46. doi: 10.1016/S0195-6701(03)00220-2
- 18. Chalbaud A, Ramos Y, Alonso Y. Antibiotic and disinfectant resistance in Acinetobacter baumannii genotyped isolates from the Caracas University Hospital. In: Mendez-Vilas A, editor. Microbes in applied research: current advances and challenges. Singapore: World Scientific Publishing Co. Pte. Ltd.; 2011. p. 481-5.
- 19. Hrenovic J, Goic-Barisic I, Kazazic S, Kovacic A, Ganjto M, Tonkic M. Carbapenem-resistant isolates of Acinetobacter baumannii from municipal wastewater treatment plant, Croatia, 2014. Euro Surveill 2016;21:pii=30195. doi: 10.2807/1560-7917.ES.2016.21.15.30195
- 20. Goic Barisic I, Towner KJ, Kovacic A, Sisko Kraljevic K, Tonkic M, Novak A, Punda-Polic V. Outbreak in Croatia caused by a new carbapenem-resistant clone of Acinetobacter baumannii producing OXA-72 carbapenemase. J Hosp Infect 2011;77:368-9. doi: 10.1016/j.jhin.2010.12.003
- 21. Tyski S, Bocian E, Grzybowska W. Reduction of the neutralisation time during antimicrobial activity testing of disinfectants according to European standards. Rocz Panstw Zakl Hig 2013;64:111-5. PMID: 23987079
- 22. Buffet-Bataillon S, Branger B, Cormier M, Bonnaure-Mallet M, Jolivet-Gougeon A. Effect of higher minimum inhibitory concentrations of quaternary ammonium compounds in clinical E. coli isolates on antibiotic susceptibilities and clinical outcomes. J Hosp Infect 2011;79:141-6. doi: 10.1016/j.jhin.2011.06.008
- 23. European Committee on Antimicrobial Susceptibility Testing (EUCAST). http://www.eucast.org/clinical_breakpoints/
- 24. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, Paterson DL, Rice LB, Stelling J, Struelens MJ, Vatopoulos A, Weber JT, Monnet DL. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012;18:268-81. doi: 10.1111/j.1469-0691.2011.03570
- 25. Célia Maria Carvalho Pereira Araújo Romão, Faria YN, Pereira LR, Asensi MD. Susceptibility of clinical isolates of multiresistant Pseudomonas aeruginosa to a hospital disinfectant and molecular typing. Mem Inst Oswaldo Cruz 2005;100:541-8. doi: 10.1590/S0074-02762005000500015
- 26. Pour NK, Dusane DH, Dhakephalkar PK, Zamin FR, Zinjarde SS, Chopade BA. Biofilm formation by Acinetobacter baumannii strains isolated from urinary tract infection and urinary catheters. FEMS Immunol Med Microbiol 2011;62:328-38. doi: 10.1111/j.1574-695X.2011.00818.x
- 27. Egington PJ, Holah J, Allison DG, Handley PS, Gilbert P. Changes in the strength of attachment of micro-organisms to surfaces following treatment with disinfectants and cleansing agents. Lett Appl Microbiol 1998;27:101-5. doi: 10.1046/j.1472-765X.1998.00390.x
- 28. Lehtola MJ, Miettinen IT, Lampola T, Hirvonen A, Vartiainen T, Martikainen PJ. Pipeline materials modify the effectiveness of disinfectants in drinking water distribution systems. Water Res 2005;39:1962-71. doi: 10.1016/j.watres.2005.03.009
- 29. Volkow P, Sánchez-Girón F, Rojo-Gutiérrez L, Cornejo-Juárez P. Hospital-acquired waterborne bloodstream infection by Acinetobacter baumannii from tap water. Infect Dis Clin Pract 2013;21:405-6. doi: 10.1097/IPC.0b013e31827f44d4
- 30. Lindford A, Kiuru V, Anttila VJ, Vuola J. Successful eradication of multidrug resistant Acinetobacter in the Helsinki burn centre. J Burn Care Res 2015;36:595-601.
- 31. Guimarães MA, Tibana A, Nunes MP, Netto dos Santos KR. Disinfectant and antibiotic activities: a comparative analysis in Brazilian hospital bacterial isolates. Braz J Microbiol 2000;31:193-9. doi: 10.1590/S1517-83822000000300008
- 32. Russell AD, Tattawasart U, Maillard JY, Furr JR. Possible link between bacterial resistance and use of antibiotics and biocides. Antimicrob Agents Chemother 1998;42:2151. PMCID: PMC105894
- 33. Qi L, Li H, Zhang C, Liang B, Li J, Wang L, Du X, Liu X, Qiu S, Song H. Relationship between antibiotic resistance, biofilm formation, and biofilm-specific resistance in Acinetobacter baumannii. Front Microbiol 2016;7:483. doi: 10.3389/fmicb.2016.00483